IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.57▲ 0.32% USD/CLP994.16▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.19% USD/ARS1,544▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC442.74— 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69— 0.00% USD/TTD6.75▲ 2.58% EUR/BRL6.25▼ 0.04% BRENT 92.94 ▼ 3.03% WTI 88.61 ▲ 0.06% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.78% GOLD 3,866 ▼ 0.52% SILVER 47.52 ▼ 3.08% SOY 1,230 ▼ 1.09% CORN 445.50 — 0.00% WHEAT 591.25 ▼ 0.34% COFFEE 281.95 ▲ 1.18% SUGAR 18.31 ▼ 0.54% ORANGE JUICE 136.85 ▼ 2.91% COTTON 81.40 ▲ 3.33% COCOA 5,181 ▲ 1.21% BEEF 220.65 ▲ 0.80% CATTLE 339.03 ▲ 1.00% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.57 ▲ 0.32% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.18% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 ▲ 1.24% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▼ 0.04% BRENT 92.94 ▼ 3.03% WTI 88.61 ▲ 0.06% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.78% GOLD 3,866 ▼ 0.52% SILVER 47.52 ▼ 3.08% SOY 1,230 ▼ 1.09% CORN 445.50 — 0.00% WHEAT 591.25 ▼ 0.34% COFFEE 281.95 ▲ 1.18% SUGAR 18.31 ▼ 0.54% ORANGE JUICE 136.85 ▼ 2.91% COTTON 81.40 ▲ 3.33% COCOA 5,181 ▲ 1.21% BEEF 220.65 ▲ 0.80% CATTLE 339.03 ▲ 1.00% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Covid-19 Brazil

ANVISA receives request for emergency use of Covaxin, the Indian Covid-19 vaccine

By · · 3 min read

RIO DE JANEIRO, BRAZIL – Brazil’s national health regulator (ANVISA) announced that on Tuesday June 29 it received the request for emergency use of the vaccine Covaxin, of experimental character, sent by the company Precisa Medicamentos, which represents in Brazil the Indian pharmaceutical company Bharat Biotech.

The company had announced yesterday that it would apply, saying that the approval is “the last remaining step for the 20 million doses negotiated with the Ministry of Health to be introduced and used in Brazil.”

Anvisa receives request for emergency use of Covaxin, Indian Covid-19 vaccine
Anvisa receives a request for emergency use of Covaxin, the Indian Covid-19 vaccine.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The pharmaceutical company’s decision comes amid controversy over the contract signed by the Ministry of Health with Precisa Medicamentos, which is being analyzed by the Covid CPI amid investigations into suspected irregularities in the purchase of doses. In addition, the negotiation is under suspicion because the unit value of the vaccines is considered high, about R$80.

According to ANVISA, the agency began examining the documents included in the request. The first 24 hours are used to screen the process and check if the documents needed for the evaluation are available. If important information is missing, ANVISA may request additional data from the lab, the agency said in a statement.

Analysis and deadline

Anvisa uses the information submitted with the application and the data previously submitted through continuous submission to evaluate the application.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Lula weighs a record 40 ministries”

According to ANVISA, the analysis of the emergency use application is done by a multidisciplinary team involving experts in drug registration, monitoring, and inspection. The time limit for analyzing the application can be seven or 30 days, depending on the individual case.

According to the rule, if there is clinical development of the vaccine in Brazil or if the report or technical opinion of the foreign health authority can demonstrate that the vaccine meets the standards of quality, efficacy, and safety established by the World Health Organization (W.H.O.) or the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) and the Pharmaceutical Inspection Cooperation Scheme (PIC/S), the deadline for evaluation is seven days.

However, the deadline is 30 days if there is no clinical development of the vaccine in Brazil or if the report or technical opinion of the foreign health authority does not demonstrate that the vaccine meets the quality, efficacy, and safety standards established by the W.H.O. or the ICH and the PIC/S.

ANVISA also reiterates that the deadline for evaluating the emergency use request does not consider the time of the process in the status of the technical request, that is, the time in which the laboratory must answer technical questions posed by the agency within the approval proceeding.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.